PlainRecalls
FDA Drug Moderate Class II Completed

Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-363-15

Reported: January 4, 2023 Initiated: December 22, 2022 #D-0091-2023

Product Description

Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-363-15

Reason for Recall

Failed impurities/degradation specifications: Out of specification for unknown impurities.

Details

Recalling Firm
AVKARE LLC
Units Affected
1237 cartons
Distribution
USA Nationwide
Location
Pulaski, TN

Frequently Asked Questions

What product was recalled?
Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-363-15. Recalled by AVKARE LLC. Units affected: 1237 cartons.
Why was this product recalled?
Failed impurities/degradation specifications: Out of specification for unknown impurities.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 4, 2023. Severity: Moderate. Recall number: D-0091-2023.